Robinson Bradshaw

Topic: ELSI

Weekly Roundup: Science Funding, DTC and Medical Device Caucusing

With so many developments at the intersection of genomics and the law, there are often a variety of interesting stories that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here we recap several recent key developments and, at bottom, round up all of the recent […]

What ELSI was New? Plenty.

From October 5 to December 8, 2009, the Genomics Law Report featured a series of thirty-six guest commentaries by industry, academic and thought leaders in the fields of genomics and personalized medicine. Entitled What ELSI is New?, the series, which we have organized into an e-book (pdf), asked each contributor to briefly respond to the following question: “What do […]

Completing the Personal Genomics Toolkit

The big news buzzing through the world of genomics this afternoon is the publication of a paper in the journal Science announcing the production of three whole-genome sequences at an average materials cost of $4,400. The work was performed by the third-generation sequencing company Complete Genomics Incorporated, along with researchers from George Church’s lab at Harvard […]

Does Familiarity Breed Acceptance? New Program Encourages Young Doctors to Get Personal with DTC Genomics.

The Genomics Law Report launched its new series What ELSI is New? yesterday with guest commentaries from Hank Greely and Misha Angrist. One of the issues that both Greely and Angrist tackle—from different angles and with decidedly different styles—is the widely acknowledged shortage of health care professionals qualified to understand and interpret genomic information of […]

What ELSI is New?

On Monday the Genomics Law Report will debut a series of guest commentaries by industry, academic and thought leaders in the fields of genomics and personalized medicine. The series is modeled on the Nature Genetics 2007 Question of the Year (“What would you do if it became possible to sequence the equivalent of a full human […]